Polaris Market Research today announced findings from its latest report, projecting the global clindamycin phosphate injection market to grow from USD 451.67 million in 2023 to USD 743.86 million by 2032, at a CAGR of 5.7% from 2024 to 2032. The report profiles 15 leading companies across two market segments and five regions, with in-depth market size, market share and competitive analysis....